WO1989010736A1 - Antibacterial dental materials - Google Patents

Antibacterial dental materials Download PDF

Info

Publication number
WO1989010736A1
WO1989010736A1 PCT/SE1989/000253 SE8900253W WO8910736A1 WO 1989010736 A1 WO1989010736 A1 WO 1989010736A1 SE 8900253 W SE8900253 W SE 8900253W WO 8910736 A1 WO8910736 A1 WO 8910736A1
Authority
WO
WIPO (PCT)
Prior art keywords
chlorhexidine
antibacterial
resin
slowly released
restorative
Prior art date
Application number
PCT/SE1989/000253
Other languages
French (fr)
Inventor
Dan W. Ericson
Original Assignee
Ericson Dan W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ericson Dan W filed Critical Ericson Dan W
Publication of WO1989010736A1 publication Critical patent/WO1989010736A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/60Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/69Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/30Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/887Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A61K6/889Polycarboxylate cements; Glass ionomer cements

Definitions

  • the present invention concerns a group of dental restorative and luting cements which have been combined with antibacterial compounds and thereby have achieved an increased antibacterial activity against oral microorganisms.
  • the cements can be based on glasspolyalkenoats or dental composite resins, to be applied in thicker layers compared to a varnish, thereby containing a larger amount of anitbacterial compounds.
  • the antibacterial compound(s) are leaking from the cement(s) which have been made soluble in oral fluids, having the properties of a matrix that allow sustained release of a drug.
  • Dental caries and perfodontitis are caused by microbial plaques on the tooth surfaces.
  • Bacteria belonging to the Streptococus mutans group are strongly associated with the developement of caries.
  • These microorganisms are highly sensitive to chlorhexidine in various forms as chlorhexidine-gluconate, chlorhexidine-acetate and chlorhexidine-hydrochloride.
  • the present invention is a thicker layer of resin or cement as carrier, which can contain substantially more chlorhexidine or other antibacterial compunds compared to a convetional varnish.
  • the present invention describes a dental cement that is in contrast to the above, highly soluble in oral fluids and will dissolve after 1-4 weeks on the teeth.
  • This important feature of the material will give a delivery system were a high concentration of an antibacterial compound is combined with a dissolving carrier, it is not an advantage to either have a non-soluble carrier (2) or lower concentration (1 ) of antibacterial compounds if one is aiming at eliminating mutans streptococci from the teeth, as in a profylactic approach towards the treatment of dental caries.
  • a restorative material is permanently placed in a cavity, the damage in terms of a cavity has already been done.
  • a non-soluble material is placed on sound dental surfaces, eventually, it will lose its antibacterial properties and become a retention site for microorganisms and increase the risk of disease.
  • the present invention can be described by the following example.
  • Glasspolyalkenoate materials such as a restorative cement (Chemfil, De Trey Dentsply Ltd, England) or a luting cement AquaCem (De Trey Dentsply) are mixed with water containing various amounts of chlorhexidine gluconate or acetate rangeing from 0 to 20 per cent.
  • Discs are made and placed on agar medium containing an inoculum of mutans streptococci or lactobacilli. After incubation, an inhibition zone is seen around the discs corresponding to the amount of chlorhexidine present in the disc. The same discs are transferred to freshly inoculated agar plates repeatedlty, until their antibacterial properties are lost.
  • the addition of chlorhexidine gives a clear dose-response inhibition of the bacterial growth.
  • the antibacterial effect is maintained through at least 15 changes of freshly inoculated bacteria with 48 hours of incubation each time. A corresponding antibacterial effect is seen when bacteria are grown in a broth medium and incubated with the chlorhexidine containing discs.
  • the high fluoride content is also important as a caries preventive measure.
  • the chlorhexidine is relased from the discs as determined by spectrophotometric measurements at 251 nm.
  • the glasspolyalkenoates has the advantage of containing a substantial amount of fluoride which is also released from the material, making the tooth structures less susceptible to decay.

Abstract

The present invention concerns a group of dental restorative and luting cements that have been combined with antibacterial compounds and thereby have achieved an increased antibacterial activity against oral microorganisms. The cements can be based on glasspolyalkenoats or dental composite resins, to be applied in thicker layers compared to a varnish, thereby containing a larger amount of antibacterial compounds. The antibacterial compound(s) are leaking from the cement(s) which have been made soluble in oral fluids, having the properties of a matrix that allow sustained release of a drug.

Description

ANTIBACTERIAL DENTAL MATERIALS
The present invention concerns a group of dental restorative and luting cements which have been combined with antibacterial compounds and thereby have achieved an increased antibacterial activity against oral microorganisms. The cements can be based on glasspolyalkenoats or dental composite resins, to be applied in thicker layers compared to a varnish, thereby containing a larger amount of anitbacterial compounds. The antibacterial compound(s) are leaking from the cement(s) which have been made soluble in oral fluids, having the properties of a matrix that allow sustained release of a drug.
Dental caries and perfodontitis are caused by microbial plaques on the tooth surfaces. Bacteria belonging to the Streptococus mutans group are strongly associated with the developement of caries. These microorganisms are highly sensitive to chlorhexidine in various forms as chlorhexidine-gluconate, chlorhexidine-acetate and chlorhexidine-hydrochloride.
Patients with extensive dental decay often carry mutans streptococci in high numbers, and a causal treatment can be to treat the patient with chlorhexidine gluconate gel, which 1s applied on the teeth in costumefit trays. By this treatment, the mutans streptococci are eliminated from the mouth for a period of time but very seldom for ever. To maintain a situation with no or occasional mutans streptococci, the treatment has to be repeated after a few months. One reason for reappearence is probably that some microorganisms persists in retentive areas where the concentration of the chlorhexidine is not bactericidal. Another reason is that the concentration of chlorhexidine in this type of treatment is high and other microorganisms will also be more or less eliminated. In an environment where several species have been more or less eliminated and then start at the same time to struggle for survival and recolonization, the mutans streptococci will soon find its ecological nisch again.
Therefore, it is apparent that if chlorhexidine could be administered in such a way that an initially high concentration is present on the teeth to eliminate all mutans streptococci and that the concentration gradually decreases allowing other microorganisms that are less sensitive to the drug to colonize first, the highly sensitive mutans streptococcus would have less chance to survive. This has been demonstrated in part by Sandham and co-workers ( 1 ). Sandhams group used a varnish However, the varnish was per definition very thin and the procedure had to be repeated at least three times, in different sessions, to be somewhat successful.
The present invention is a thicker layer of resin or cement as carrier, which can contain substantially more chlorhexidine or other antibacterial compunds compared to a convetional varnish.
The idea to mix antibacterial compounds such as chlorhexidine with dental restorative materials is not new Jedrychowski and co-workers have described a combination of chlorhexidine with composite resin or glass polyalkenoate cements (2). By mixing the antibacterial compund with the restorative materials, they achieved antibacterial effects without comprising the mechanical properties of such materials.
The present invention describes a dental cement that is in contrast to the above, highly soluble in oral fluids and will dissolve after 1-4 weeks on the teeth. This important feature of the material will give a delivery system were a high concentration of an antibacterial compound is combined with a dissolving carrier, it is not an advantage to either have a non-soluble carrier (2) or lower concentration (1 ) of antibacterial compounds if one is aiming at eliminating mutans streptococci from the teeth, as in a profylactic approach towards the treatment of dental caries. If a restorative material is permanently placed in a cavity, the damage in terms of a cavity has already been done. If a non-soluble material is placed on sound dental surfaces, eventually, it will lose its antibacterial properties and become a retention site for microorganisms and increase the risk of disease.
The present invention can be described by the following example. Glasspolyalkenoate materials such as a restorative cement (Chemfil, De Trey Dentsply Ltd, England) or a luting cement AquaCem (De Trey Dentsply) are mixed with water containing various amounts of chlorhexidine gluconate or acetate rangeing from 0 to 20 per cent. Discs are made and placed on agar medium containing an inoculum of mutans streptococci or lactobacilli. After incubation, an inhibition zone is seen around the discs corresponding to the amount of chlorhexidine present in the disc. The same discs are transferred to freshly inoculated agar plates repeatedlty, until their antibacterial properties are lost. The results show that the cements has a small antibacterial effect even without addition of chlorhexidine, perhaps due to the high fluoride content. The addition of chlorhexidine gives a clear dose-response inhibition of the bacterial growth. The antibacterial effect is maintained through at least 15 changes of freshly inoculated bacteria with 48 hours of incubation each time. A corresponding antibacterial effect is seen when bacteria are grown in a broth medium and incubated with the chlorhexidine containing discs. The high fluoride content is also important as a caries preventive measure.
When exceding 10 per cent of chlorhexidine in added water to the cements, a substantially higher solubility of the cements is seen. As an example, the addition of 15 per cent chlorhexidine gluconate to the luting cement will render it totally dissolved after 8-10 changes in agar plates as described above. This is an example how the glasspolyalkenoates can become soluble by the addition of high concentrations of chlorhexidine. This addition does not dramatically affect the adhesive properties of the materials and they will attach to dental surfaces even containing high amounts of chlorhexidine. If a lower concentration of chlorhexidine is used the material could be used as a temporary filling material.
The chlorhexidine is relased from the discs as determined by spectrophotometric measurements at 251 nm.
The glasspolyalkenoates has the advantage of containing a substantial amount of fluoride which is also released from the material, making the tooth structures less susceptible to decay.
The above presented formulations of glasspolyalkenoates and chlorhexidine are commonly used in dentistry and they have a low toxicity. Of course, the concept of the invention can be applied not only on glasspolyalkenoates and chlorhexidine, but also dental resin materials and other materials combined with other antibacterial compounds.
Literature cited:
1. Sandham, HJ et al. 1988. A preliminary report on long-term elimination of detectable mutans streptococci in man. Journal of Dental Research 67( 1 ):9-14
2. Jedrychowski JR et al. 1983. Antibacterial and mechanical properties of restorative materials combined with itatio 1 : 373- 81

Claims

Cl aims:
1. A dental cement-, resin- or restorative material containing an antibacterial compound as for example chlorhexidine, which is slowly released from said material.
2. A dental cement-, resin- or restorative material adhering to tooth surfaces and containing an antibacterial compound as for example chlorhexidine, which is slowly released from said material.
3. A glasspolyalkenoate material according to claims 1 and 2 containing 10 - 40 per cent chlorhexidine (gluconate, acetate or hydrochloride) which is slowly released.
4. A glasspolyalkenoate material according to claim 3, that has been made soluble in oral fluids by the addition of chlorhexdine
5. A glasspolyalkenoate material containing chlorhexidine up to 15 per cent or other antibacteraial compound where the glasspolyalkenoate has been made soluble by the addition of other compounds.
6. A dental cement-, resin- or restorative material containing an antibacterial compound as for example chlorhexidine, which is slowly released from said material that has the properties of beeing soluble in oral fluids
7. A dental cement-, resin- or restorative material containing an antibacterial compound as for example chlorhexidine, which is slowly released from said material that has the properties of beeing completely soluble in oral fluids in 5 to 25 days.
8. A dental cement-, resin- or restorative material adhering to tooth structures containing an antibacterial compound as for example chlorhexidine, which is slowly released from said material that has the properties of beeing completely soluble in oral fluids in 5 to 25 days.
9. A material according to claims 1 - 8 containing fluoride.
10. A material according to claims 1 - 9 that can be applied on a tooth surface in a substantially thicker layer as compared to a conventional varnish.
PCT/SE1989/000253 1988-05-06 1989-05-05 Antibacterial dental materials WO1989010736A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8801719A SE8801719D0 (en) 1988-05-06 1988-05-06 ANTIBACTERIAL DENTIFICATION AND CEMENTATION MATERIAL
SE8801719-9 1988-05-06

Publications (1)

Publication Number Publication Date
WO1989010736A1 true WO1989010736A1 (en) 1989-11-16

Family

ID=20372255

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1989/000253 WO1989010736A1 (en) 1988-05-06 1989-05-05 Antibacterial dental materials

Country Status (2)

Country Link
SE (1) SE8801719D0 (en)
WO (1) WO1989010736A1 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357327A2 (en) * 1988-08-25 1990-03-07 National Research Development Corporation Sustained release device
DE4019617A1 (en) * 1990-06-20 1992-01-02 Thera Ges Fuer Patente IMPLANTABLE ACTIVE SUBSTITUTE MATERIAL
US5156835A (en) * 1987-01-30 1992-10-20 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5178851A (en) * 1987-01-30 1993-01-12 Colgate-Palmolive Company Antiplaque antibacterial oral composition
US5180578A (en) * 1987-01-30 1993-01-19 Colgate-Palmolive Company Antibacterial antiplaque anticalculus oral composition
US5188821A (en) * 1987-01-30 1993-02-23 Colgate-Palmolive Company Antibacterial antiplaque oral composition mouthwash or liquid dentifrice
US5192531A (en) * 1988-12-29 1993-03-09 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5192530A (en) * 1987-01-30 1993-03-09 Colgate-Palmolive Company Antibacterial antiplaque oral composition
WO1997047272A1 (en) * 1996-06-14 1997-12-18 Minnesota Mining And Manufacturing Company Glass ionomer cement
WO1999042080A2 (en) * 1998-02-19 1999-08-26 Oraceutical, Llc Curable compositions with antimicrobial properties
DE19813686A1 (en) * 1998-03-27 1999-09-30 Roeko Gmbh & Co Agent for treatment or filling of a tooth root canal containing antibacterial and optionally carriers and fillers
EP1123060A2 (en) * 1998-09-24 2001-08-16 Advantage Dental Products Inc. Calcified tissue facing preparation containing an antimicrobial agent
WO2001074321A2 (en) * 2000-04-03 2001-10-11 Chx Technologies Inc. Use of chlorhexidine in the prevention of root caries
WO2003105785A1 (en) * 2002-06-12 2003-12-24 Stick Tech Oy Antimicrobial prepreg, composite and their use
US6726899B2 (en) 1998-09-24 2004-04-27 Advantage Dental Products, Inc. Calcified tissue facing preparation containing antimicrobial agent
EP2384733A1 (en) 2010-05-07 2011-11-09 Ivoclar Vivadent AG Antimicrobial dental materials
US20130303622A1 (en) * 2010-04-05 2013-11-14 Uniao Brasileira De Educacao E Assistencia Mantenedora Da Puc Rs Aqueous anti-microbial solution containing chlorhexidine digluconate and tartaric acid, method for preparing same, and anti-microbial orthodontic cement
US8933147B2 (en) 2005-11-17 2015-01-13 3M Innovative Properties Company Anti-microbial dental impression material

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0128655A2 (en) * 1983-05-11 1984-12-19 The University Of Toronto Innovations Foundation Benzoin antimicrobial dental varnishes
EP0140766A2 (en) * 1983-10-07 1985-05-08 The Forsyth Dental Infirmary For Children Intra pocket drug delivery devices for treatment of periondontal diseases
EP0223245A2 (en) * 1985-11-21 1987-05-27 Mitsui Petrochemical Industries, Ltd. Curable compositions for dental drugs having sustained release property
EP0243002A2 (en) * 1986-03-25 1987-10-28 Rohto Pharmaceutical Co., Ltd. Pharmaceutical composition for the treatment of periodontal diseases
EP0264660A2 (en) * 1986-10-11 1988-04-27 Ivoclar AG Use of a dental material for combating caries and periodontosis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0128655A2 (en) * 1983-05-11 1984-12-19 The University Of Toronto Innovations Foundation Benzoin antimicrobial dental varnishes
EP0140766A2 (en) * 1983-10-07 1985-05-08 The Forsyth Dental Infirmary For Children Intra pocket drug delivery devices for treatment of periondontal diseases
EP0223245A2 (en) * 1985-11-21 1987-05-27 Mitsui Petrochemical Industries, Ltd. Curable compositions for dental drugs having sustained release property
EP0243002A2 (en) * 1986-03-25 1987-10-28 Rohto Pharmaceutical Co., Ltd. Pharmaceutical composition for the treatment of periodontal diseases
EP0264660A2 (en) * 1986-10-11 1988-04-27 Ivoclar AG Use of a dental material for combating caries and periodontosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Vol. 99, (1983), abstract no. 99:181435h, J. Oral Rehabil. 1983, 10(5), 373-81 (Eng). *

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5156835A (en) * 1987-01-30 1992-10-20 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5178851A (en) * 1987-01-30 1993-01-12 Colgate-Palmolive Company Antiplaque antibacterial oral composition
US5180578A (en) * 1987-01-30 1993-01-19 Colgate-Palmolive Company Antibacterial antiplaque anticalculus oral composition
US5188821A (en) * 1987-01-30 1993-02-23 Colgate-Palmolive Company Antibacterial antiplaque oral composition mouthwash or liquid dentifrice
US5192530A (en) * 1987-01-30 1993-03-09 Colgate-Palmolive Company Antibacterial antiplaque oral composition
EP0357327A2 (en) * 1988-08-25 1990-03-07 National Research Development Corporation Sustained release device
EP0357327A3 (en) * 1988-08-25 1990-10-03 National Research Development Corporation Sustained release device
US5192531A (en) * 1988-12-29 1993-03-09 Colgate-Palmolive Company Antibacterial antiplaque oral composition
DE4019617A1 (en) * 1990-06-20 1992-01-02 Thera Ges Fuer Patente IMPLANTABLE ACTIVE SUBSTITUTE MATERIAL
WO1997047272A1 (en) * 1996-06-14 1997-12-18 Minnesota Mining And Manufacturing Company Glass ionomer cement
US6136885A (en) * 1996-06-14 2000-10-24 3M Innovative Proprerties Company Glass ionomer cement
WO1999042080A3 (en) * 1998-02-19 1999-10-07 Oraceutical Llc Curable compositions with antimicrobial properties
WO1999042080A2 (en) * 1998-02-19 1999-08-26 Oraceutical, Llc Curable compositions with antimicrobial properties
US6281265B1 (en) 1998-02-19 2001-08-28 Salim A. Nathoo Curable compositions with antimicrobial properties
EP0951893A2 (en) * 1998-03-27 1999-10-27 ROEKO GmbH + Co. Dentalerzeugnisse Antibacterial filling for root canals and method of manufacturing
EP0951893A3 (en) * 1998-03-27 2001-09-05 ROEKO GmbH + Co. Dentalerzeugnisse Antibacterial filling for root canals and method of manufacturing
DE19813686A1 (en) * 1998-03-27 1999-09-30 Roeko Gmbh & Co Agent for treatment or filling of a tooth root canal containing antibacterial and optionally carriers and fillers
US6726899B2 (en) 1998-09-24 2004-04-27 Advantage Dental Products, Inc. Calcified tissue facing preparation containing antimicrobial agent
EP1123060A2 (en) * 1998-09-24 2001-08-16 Advantage Dental Products Inc. Calcified tissue facing preparation containing an antimicrobial agent
EP1123060A4 (en) * 1998-09-24 2005-03-16 Advantage Dental Products Inc Calcified tissue facing preparation containing an antimicrobial agent
US6494717B1 (en) * 1998-09-24 2002-12-17 Advantage Dental Products, Inc. Calcified tissue facing preparation containing an antimicrobial agent
WO2001074321A2 (en) * 2000-04-03 2001-10-11 Chx Technologies Inc. Use of chlorhexidine in the prevention of root caries
WO2001074321A3 (en) * 2000-04-03 2002-05-16 Chx Technologies Inc Use of chlorhexidine in the prevention of root caries
WO2003105785A1 (en) * 2002-06-12 2003-12-24 Stick Tech Oy Antimicrobial prepreg, composite and their use
US8933147B2 (en) 2005-11-17 2015-01-13 3M Innovative Properties Company Anti-microbial dental impression material
US20130303622A1 (en) * 2010-04-05 2013-11-14 Uniao Brasileira De Educacao E Assistencia Mantenedora Da Puc Rs Aqueous anti-microbial solution containing chlorhexidine digluconate and tartaric acid, method for preparing same, and anti-microbial orthodontic cement
EP2384733A1 (en) 2010-05-07 2011-11-09 Ivoclar Vivadent AG Antimicrobial dental materials

Also Published As

Publication number Publication date
SE8801719D0 (en) 1988-05-06

Similar Documents

Publication Publication Date Title
WO1989010736A1 (en) Antibacterial dental materials
Goodson Dental applications
Siqueira Jr et al. Intracanal medicaments: evaluation of the antibacterial effects of chlorhexidine, metronidazole, and calcium hydroxide associated with three vehicles
Christersson et al. Topical application of tetracycline‐HCl in human periodontitis
Fraga et al. In vitro evaluation of antibacterial effects of photo-cured glass ionomer liners and dentin bonding agents during setting
Evans et al. Efficacy of calcium hydroxide: chlorhexidine paste as an intracanal medication in bovine dentin
Moellering Jr Emergence of Enterococcus as a significant pathogen
US4406881A (en) Antimicrobial agent
Spahr et al. Effect of the enamel matrix derivative Emdogain® on the growth of periodontal pathogens in vitro
Siqueira Jr et al. Antibacterial activities of root canal sealers against selected anaerobic bacteria
JP2587855B2 (en) Periodontal disease treatment composition
AU646025B2 (en) Dentifrice inhibiting dental plaque
Hoshino et al. Bactericidal efficacy of metronidazole against bacteria of human carious dentin in vitro
US5385728A (en) Antimicrobial etchants
US20100266990A1 (en) Dental antimicrobial formulations and methods of using the same
Brännström et al. Materials techniques for lining composite resin restorations: a critical approach
Heys et al. Microleakage of three cement bases
Flemmig et al. Adjunctive controlled topical application of tetracycline HCl in the treatment of localized persistent or recurrent periodontitis: Effects on clinical parameters and elastase‐α1‐proteinase inhibitor in gingival crevicular fluid
Tronstad et al. Controlled release of medicaments in endodontic therapy
Barkhordar et al. Antimicrobial action of glass-ionomer lining cement on S. sanguis and S. mutans
De Graaff et al. The role of Actinobacillus actinomycetemcomitans in periodontal disease
US5167952A (en) Therapeutic composition formulated as a dental rinse that stimulates Prostaglandin synthesis in the mouth to prevent plaque buildup on the teeth and Periodontal disease
El-Kafrawy et al. Pulp reaction to a polycarboxylate cement in monkeys
US6602516B1 (en) Antibiotic/medicated gutta percha point
EP1115385B1 (en) Use of a composition for manufacturing a medicament for the prevention and treatment of parodontitis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE